➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: September 17, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,559,183

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,559,183
Title: Nano-emulsion of 5-aminolevulinic acid
Abstract:The present invention relates to a composition comprising a nano-emulsion that contains 5-aminolevulinic acid as well as a carrier in an aqueous phase. This invention also relates to a pharmaceutical preparation containing this composition. The nano-emulsions of this type can be used in photodynamic therapy as well as in the photodiagnostic detection of proliferatives cells.
Inventor(s): Schmid; Hans W. (Zug, CH), Burmeister; Gerd (Oberarth, CH)
Assignee: ASAT AG Applied Science & Technology (Zug, CH)
Application Number:09/831,564
Patent Claim Types:
see list of patent claims
Composition; Compound; Device; Process; Use;

Drugs Protected by US Patent 6,559,183

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,559,183

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany198 52 245Nov 12, 1998
PCT Information
PCT FiledNovember 12, 1999PCT Application Number:PCT/EP99/08711
PCT Publication Date:May 25, 2000PCT Publication Number: WO00/28971

International Family Members for US Patent 6,559,183

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 260092 ⤷  Try it Free
Australia 1271000 ⤷  Try it Free
Australia 758098 ⤷  Try it Free
Canada 2351620 ⤷  Try it Free
Germany 19852245 ⤷  Try it Free
Germany 59908665 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.